Empagliflozin
Empagliflozin is a potent and highly selective SGLT2 inhibitor (IC50=3.1 nM) with over 300-fold selectivity against related transporters. It is widely used in research for type 2 diabetes, facilitating in vitro mechanistic studies and in vivo models investigating glycemic control and cardiorenal outcomes.
Product Specifications
CAS Number
864070-44-0
Product Name Alternative
Inhibit, Inhibitor, Empagliflozin, BI10773, BI-10773, BI 10773, SGLT6, SGLT4, SGLT5, SGLT, SGLT1, SGLT2, Sodium-dependent glucose cotransporters
Field of Research
Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:8.3 mg/mL (18.41 mM) ; DMSO:242.5 mg/mL (537.8 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
O[C@H]1[C@H] (C2=CC (CC3=CC=C (O[C@H]4CCOC4) C=C3) =C (Cl) C=C2) O[C@H] (CO) [C@@H] (O) [C@@H]1O
Molecular Formula
C23H27ClO7
Molecular Weight
450.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
AKT1S1 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
AKT1S1 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
